KLRG1 and metabolic syndrome: In participants with metabolic syndrome, the proportion of KLRG1+CD28− cells increased by 14 % in unadjusted analyses, and by 18 % in adjusted analyses (Unadjusted P = 0.05, adjusted P = 0.04), compared to those without metabolic syndrome (Table 2).